Concepedia

Christine Flefleh

CF

10

Publications

482

Citations

10

H-Index

2001

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Christine Flefleh is an author at Bristol-Myers Squibb (United States) specializing in radiation oncology, cancer research, and medicine.

Top concepts

Publications per year

2001–2008

10

Publications

10

Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure

Feng Luo, Zheng Yang, Amy Camuso et al. · Clinical Cancer Research · 2006 · 149 citations

Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft

Feng Luo, Zheng Yang, Huijing Dong et al. · Cancer Chemotherapy and Pharmacology · 2005 · 85 citations

, , +7

Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels

Robert A. Wild, Krista Fager, Christine Flefleh et al. · Molecular Cancer Therapeutics · 2006 · 62 citations

, , +14

Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.

Rosalyn D. Blumenthal, Chris Waskewich, David M. Goldenberg et al. · PubMed · 2001 · 51 citations

BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo

Francis Y. Lee, Louis J. Lombardo, Amy Camuso et al. · Cancer Research · 2005 · 41 citations

, , +19

Rows per page

1–5 of 10